These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15771229)

  • 21. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive downmodulation of plasmacytoid dendritic cell functions by vitamin D3 analogue calcipotriol.
    Suzuki T; Tatsuno K; Ito T; Sakabe JI; Funakoshi A; Tokura Y
    J Dermatol Sci; 2016 Oct; 84(1):71-79. PubMed ID: 27342039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Derivatives of cholecalciferol in the treatment of psoriasis].
    Aĭziatulov RF; Iukhymenko VV
    Lik Sprava; 2003; (2):8-12. PubMed ID: 12774464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating transdermal delivery of vitamin D3.
    Alsaqr A; Rasoully M; Musteata FM
    AAPS PharmSciTech; 2015 Aug; 16(4):963-72. PubMed ID: 25609377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriasis treatment with vitamin D derivatives.
    Menné T; Larsen K
    Semin Dermatol; 1992 Dec; 11(4):278-83. PubMed ID: 1337262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prescribe topical treatments for psoriasis].
    Lorette G; Fontès V
    Rev Prat; 2004 Jan; 54(1):40-2. PubMed ID: 15049598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.
    Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I
    Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure.
    Adachi Y; Uchida N; Matsuo T; Horio T
    Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):16-8. PubMed ID: 18201352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topical treatment of psoriasis with calcipotriol. Report of clinical experience].
    Hofmann C; Schirle S
    Fortschr Med; 1993 Dec; 111(35-36):562-4. PubMed ID: 8307546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral calcium tolerance test in extensive psoriasis treated with topical calcipotriol.
    Gumowski-Sunek D; Rizzoli R; Saurat JH
    Dermatology; 1995; 190(1):43-7. PubMed ID: 7894096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent developments in vitamin D analogs.
    Fogh K; Kragballe K
    Curr Pharm Des; 2000 Jun; 6(9):961-72. PubMed ID: 10828319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheological properties of three different vitamin D ointments and their clinical perception by patients with mild to moderate psoriasis.
    Marty JP; Lafforgue C; Grossiord JL; Soto P
    J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():7-10. PubMed ID: 16274405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs.
    Jensen M; Groth L; Hølmer G; Hansen HS; Fullerton A
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):401-13. PubMed ID: 12476014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
    J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New treatment of psoriasis with the vitamin D analogue calcipotriol].
    Austad J
    Tidsskr Nor Laegeforen; 1993 Nov; 113(29):3580-1. PubMed ID: 8273098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical calcipotriol (MC 903) for psoriasis: a clinical study.
    Mozzanica N; Cattaneo A; Schmitt E; Legori A; Finzi AF
    Acta Derm Venereol Suppl (Stockh); 1994; 186():169-70. PubMed ID: 8073826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.
    Kragballe K; Fogh K; Søgaard H
    Acta Derm Venereol; 1991; 71(6):475-8. PubMed ID: 1685828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment.
    Nissen JB; Avrach WW; Hansen ES; Stengaard-Pedersen K; Kragballe K
    Dermatology; 1999; 198(1):11-7. PubMed ID: 10026395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment.
    van der Vleuten CJ; van de Kerkhof PC
    Drugs; 2001; 61(11):1593-8. PubMed ID: 11577796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcipotriol induces apoptosis in psoriatic keratinocytes.
    Tiberio R; Bozzo C; Pertusi G; Graziola F; Gattoni M; Griffanti P; Boggio P; Colombo E; Leigheb G
    Clin Exp Dermatol; 2009 Dec; 34(8):e972-4. PubMed ID: 19758385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.